[ij] [ij] [ij] 
Email id

Asian Journal of Research in Pharmaceutical Science
Year : 2020, Volume : 10, Issue : 3
First page : ( 224) Last page : ( 232)
Print ISSN : 2231-5640. Online ISSN : 2231-5659.
Article DOI : 10.5958/2231-5659.2020.00041.7

Structure and physiology of ppar- γ receptor, as well as its effect on pancreatic cancer effect of tzds on adipokines

Patil Sushmita V.*, Shimpi Amit A., Shaikh Azam Z.

Department of Pharmaceutical Chemistry, Ahinsa Institute of Pharmacy, Dhule Road, Dondaicha-425408

*Corresponding Author E-mail: sushmitavpatil1705@gmail.com

Online published on 16 September, 2020.


The peroxisome proliferator-activated receptors (PPARs) feel right to the nuclear hormone receptor marvelous ancestors. To date, three singular PPAR isotopes, namely PPAR-α, -δ, and -γ, have been branded in vertebrates and have different patterns of tissue allocation. Like all nuclear receptors, the human PPAR-γ (hPPAR-γ) is characterized by a modular arrangement composed of an N-terminal A/B domain, a DNA-binding domain among two zinc fingers (C domain), a D domain, and a C-terminal ligand-binding domain (E/F domain). Human PPAR-γ exists in two protein isoforms, hPPAR-γ1 and -γ2, with different lengths of the N-terminal. Pancreatic cancer is one of the most deadly forms of human cancer. Several molecular abnormalities habitually nearby in pancreatic cancer have been distinct and comprise mutations in K-ras, p53, p16 and DPC4 genes. Nuclear receptor Peroxisome Proliferator-Activated Receptor gamma (PPARγ) has a function in numerous carcinomas and has been originate to be over articulated in pancreatic cancer. It plays normally a swelling suppressor role antagonizing proteins promoting carcinogenesis such as NF-κB and TGFβ. This review of the existing journalism places of interest is Structure and physiological functions of the human PPRAγ, examine PPARγ in pancreatic cancerand type 2 diabetes, and their association to additional pathways imperative in pancreatic carcinogenesis.



PPAR-γ, Adipogenesis, Insulin resistance, Thiazolidinediones, Pancreatic cancer.


║ Site map ║ Privacy Policy ║ Copyright ║ Terms & Conditions ║ Page Rank Tool
691,042,580 visitor(s) since 30th May, 2005.
All rights reserved. Site designed and maintained by DIVA ENTERPRISES PVT. LTD..
Note: Please use Internet Explorer (6.0 or above). Some functionalities may not work in other browsers.